Table 1.
Socio-demographic characteristics of participants for adherent vs non-adherent participants
| Characteristics | Total (n = 331) |
Non-adherent (n = 113; 34.1%) |
Adherent (n = 218; 65.9%) |
p-value |
|---|---|---|---|---|
| Age (mean, SD) | 33.3 (9.4) | 31.3 (9.4) | 34.3 (9.2) | |
| 18–27 years | 43 (38.1) | 53 (24.3) | 0.019 | |
| 28–37 years | 44 (38.9) | 91 (41.7) | ||
| Above 38 years | 26 (23.0) | 74 (33.9) | ||
| Gender | 0.202 | |||
| Female | 204 (61.6) | 75 (66.4) | 129 (59.2) | |
| Male | 127 (38.4) | 38 (33.6) | 89 (40.8) | |
| Marital Status | 0.331 | |||
| Not-married | 104 (31.4) | 31 (27.4) | 73 (33.5) | |
| Married | 200 (60.4) | 70 (61.9) | 130 (59.6) | |
| Divorced/widowed | 27 (8.2) | 12 (10.6) | 15 (6.9) | |
| Having Children | 0.259 | |||
| No | 101 (30.5) | 30 (26.5) | 71 (32.0) | |
| Yes | 230 (69.5) | 83 (73.5) | 147 (67.4) | |
| Education | 0.309 | |||
| Elementary school | 7 (2.1) | 1 (0.9) | 6 (2.8) | |
| Junior high school | 28 (8.5) | 7 (6.2) | 21 (9.6) | |
| High school | 70 (21.1) | 30 (26.5) | 40 (18.3) | |
| Vocational | 171 (51.7) | 57 (50.4) | 114 (52.3) | |
| University | 8 (2.4) | 4 (3.5) | 4 (1.8) | |
| Master | 47 (14.2) | 14 (12.4) | 33 (15.1) | |
| Employment | 0.076 | |||
| Unpaid | 139 (42.0) | 55 (48.7) | 84 (38.5) | |
| Paid | 192 (58.0) | 58 (51.3) | 134 (61.5) | |
| Sexual Orientation | 0.335 | |||
| Homosexual | 9 (2.7) | 1 (0.9) | 8 (3.7) | |
| Bisexual | 3 (0.9) | 1 (0.9) | 2 (0.9) | |
| Heterosexual | 319 (96.4) | 111 (98.2) | 208 (95.4) | |
| Religion | 0.464 | |||
| Protestant | 247 (74.6) | 88 (77.9) | 159 (72.9) | |
| Catholic | 22 (6.6) | 8 (7.1) | 14 (6.4) | |
| Moslim | 62 (18.7) | 17 (15.0) | 45 (20.6) | |
| Ethnicity | 0.023 | |||
| Non-Papuan | 109 (32.9) | 28 (24.8) | 81 (37.2) | |
| Papuan | 222 (67.1) | 85 (75.2) | 137 (62.8) | |
| Support in medicine-taking from social network | 0.280 | |||
| No support | 113 (34.1) | 43(38.1) | 70 (32.1) | |
| Support | 218 (65.9) | 70 (61.9) | 148 (67.9) | |
| Regimen | 0.248 | |||
| Duv-EFV | 9 (1.2) | 1 (0.9) | 8 (3.7) | |
| Duv-NEV | 29 (2.7) | 7 (6.2) | 22 (10.1) | |
| FDC | 144 (43.5) | 48 (42.5) | 96 (44.0) | |
| TDF-3TC-Aluvia | 2 (0.6) | 1 (0.9) | 1 (0.5) | |
| TDF-3TC-EFV | 59 (17.8) | 18 (15.9) | 41 (18.8) | |
| TDF-3TC-NEV | 10 (3.0) | 2 (1.8) | 8 (3.7) | |
| TDF-FTC-Aluvia | 3 (0.9) | 1 (0.9) | 2 (0.9) | |
| TDF-FTC-EFV | 70 (21.1) | 33 (29.2) | 37 (17.0) | |
| TDF-FTC-NEV | 1 (0.3) | 0 (0.0) | 1 (0.5) |
*SD Standard Deviation, Duv Duviral, EFV Efavirenz, NEV Nevirapine, FDC Fixed Dose Combination (TDF + 3TC + Efavirenz), TDF Tenofovir, 3TC Lamivudine, FTC Emtricitabine
*p value according to Chi square test